Have a new drug that promis­es to fight Covid-19? The FDA promis­es fast ac­tion but some de­vel­op­ers aren't hap­py

Af­ter pro­vid­ing an emer­gency ap­proval to use malar­ia drugs against coro­n­avirus with lit­tle ac­tu­al ev­i­dence of their ef­fi­ca­cy or safe­ty in that set­ting, the FDA has al­ready proven that it has set aside the gold stan­dard when it comes to the pan­dem­ic. And now reg­u­la­tors have spelled out a new ap­proach to speed­ing de­vel­op­ment that promis­es im­me­di­ate re­spons­es in no un­cer­tain terms — promis­ing a pro­gram of­fer­ing the ul­ti­mate high-speed path­way to Covid-19 drug ap­provals.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.